Hope it does, they have made the place into a rat hole, this place is in the middle of no options...they go and spend 500 million to outsource IS to IbM then they spend another 500 million to bring it back, seriously if other companies can manage outsourcing IS why can't we? The CIO Dmckenzie approved the outsourcing and now she brings it back in-house...wastage to the nth degree today we RIFd stellar scientists and have the so called leadership teams bring us down seriously what has DMcken contributed to our bottom line? Why did the board approve the reverse transition of IS? It is OK to flush the Amgen shareholders and staff livelihood down the toilet...and it's OK to RIF real contributors to our innovation WoW! Am I missing something?